New York State Common Retirement Fund
CTNM

New York State Common Retirement Fund’s Contineum Therapeutics CTNM Stock Holding History

New York State Common Retirement Fund’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-600
Closed -$4.19K – 3371
2025
Q1 		$4.19K Hold
600
– – ﹤0.01% 3133
2024
Q4 		$8.79K Hold
600
– – ﹤0.01% 3117
2024
Q3 		$11.5K Sell
600
-4,800
-89% -$92K ﹤0.01% 3097
2024
Q2 		$95.1K Buy
+5,400
New +$87K ﹤0.01% 2888

Other funds holding CTNM

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

New York State Common Retirement Fund's CTNM Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Contineum Therapeutics (CTNM) in Q2 2025, closing a stake of 600 shares — an estimated $4.19K sold.

New York State Common Retirement Fund first reported a position in CTNM in Q2 2024 and held it in 4 quarters. The position peaked at $95.1K in Q2 2024. 70 funds tracked by Wall St. Rank hold CTNM as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Contineum Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 600 Contineum Therapeutics shares in Q2 2025, an estimated $4.19K.
  • New York State Common Retirement Fund first reported a position in Contineum Therapeutics in Q2 2024 and held it in 4 quarters.
  • New York State Common Retirement Fund's Contineum Therapeutics position peaked at $95.1K in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.